Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne)

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Virology

• Publication date

  1988-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.62.8.2587-2595.1988PMID 3292789PMCID PMC253688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of simian immunodeficiency virus isolates

  1988cited by this paper
• Chemical synthesis of a retroviral nucleic acid binding protein

  1988cited by this paper
• Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2

  1988cited by this paper
• Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses

  1987cited by this paper
• Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses

  1987cited by this paper
• Genome organization and transactivation of the human immunodeficiency virus type 2

  1987cited by this paper
• Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins.

  1987cited by this paper
• Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins

  1987cited by this paper
• Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa.

  1987cited by this paper
• Characterization of mouse mammary tumor virus gag-pro gene products and the ribosomal frameshift site by protein sequencing.

  1987cited by this paper
• Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain.

  1987cited by this paper
• The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein.

  1987cited by this paper
• Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys).

  1986cited by this paper
• Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome.

  1986cited by this paper
• Seroepidemiologic survey of captive old‐world primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys)

  1986cited by this paper
• Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses

  1986influential reference
• Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins

  1986cited by this paper
• Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys

  1986cited by this paper
• Isolation of a new human retrovirus from West African patients with AIDS.

  1986influential reference
• Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease

  1985influential reference
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera.

  1985cited by this paper
• Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity.

  1985cited by this paper
• Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa.

  1985cited by this paper
• Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus

  1985cited by this paper
• Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon.

  1985cited by this paper
• Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.

  1985cited by this paper
• Nucleotide sequence of the AIDS virus, LAV.

  1985cited by this paper
• Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.

  1985cited by this paper
• Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK.

  1985cited by this paper
• Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III.

  1985cited by this paper
• Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products

  1984influential reference
• Complete amino acid sequence of the basic nucleic acid binding protein of feline leukemia virus.

  1984cited by this paper
• Complete amino acid sequence of human T‐cell leukemia virus structural protein p15

  1983cited by this paper
• Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification.

  1983cited by this paper
• Complete amino acid sequence of the nucleic acid‐binding protein of bovine leukemia virus

  1983cited by this paper
• In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid

  1983cited by this paper
• Reversed Phase (RP) HPLC of Proteins and Peptides and Its Impact on Protein Microsequencing

  1982cited by this paper
• Chemical synthesis and sequencing of peptides and proteins

  1982cited by this paper
• Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses.

  1981cited by this paper
• Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus.

  1978cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

  1967cited by this paper

• Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies

  2025cites this paper
• The life cycle of feline immunodeficiency virus.

  2024cites this paper
• Expression, purification, and functional characterization of soluble recombinant full-length simian immunodeficiency virus (SIV) Pr55Gag

  2023influential citation
• Stephan Oroszlan and the Proteolytic Processing of Retroviral Proteins: Following A Pro

  2021cites this paper
• Clinical Evidence and Therapeutic Treatments at the Time of the Coronaviruses Responsible for SARS: A Perspective Point of View.

  2020cites this paper
• Microbial gas vesicles as nanotechnology tools: exploiting intracellular organelles for translational utility in biotechnology, medicine and the environment

  2020influential citation
• Proteinase Inhibitors

  2020cites this paper
• Coronavirus envelope protein: current knowledge

  2019cites this paper
• Construction of a novel SHIV having an HIV-1-derived protease gene and its infection to rhesus macaques: a usefu1 tool to conduct in vivo efficacy tests for protease inhibitors

  2018cites this paper
• Disrupting the CD95–PLCγ1 interaction prevents Th17-driven inflammation

  2018cites this paper
• Cross-subtype detection of HIV-1 using reverse transcription and recombinase polymerase amplification.

  2016cites this paper
• ATP generation in a host cell in early-phase infection is increased by upregulation of cytochrome c oxidase activity via the p2 peptide from human immunodeficiency virus type 1 Gag

  2015cites this paper
• Retrospective on the all-in-one retroviral nucleocapsid protein

  2014cites this paper
• Understanding the Process of Envelope Glycoprotein Incorporation into Virions in Simian and Feline Immunodeficiency Viruses

  2014cites this paper
• Knockdown of the Cellular Protein LRPPRC Attenuates HIV-1 Infection

  2012cites this paper
• Validating the vitality strategy for fighting drug resistance

  2012cites this paper
• Identification of novel cellular components associated with HIV-1 early nucleoprotein complexes

  2012cites this paper
• Mapping of the Self-Interaction Domains in the Simian Immunodeficiency Virus Gag Polyprotein

  2011cites this paper
• Role of Protein Flexibility in Function, ResistancePathways and Substrate Recognition Specificity in HIV-1 Protease: A Dissertation

  2011cites this paper
• Role of Protein Flexibility in Function, Resistance Pathways and Substrate Recognition Specific ity in HIV-1 Protease: A Dissertation

  2011cites this paper
• Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors

  2010cites this paper
• Comparative Studies on Retroviral Proteases: Substrate Specificity

  2010cites this paper
• Analysis of correlations between energy and residue fluctuations in native proteins and determination of specific sites for binding.

  2009cites this paper
• Myristoylation of the small envelope protein of porcine reproductive and respiratory syndrome virus is non-essential for virus infectivity but promotes its growth

  2009influential citation
• Specificity of retroviral proteinases based on substrates containing tyrosine and proline at the site of cleavage

  2008cites this paper
• The SIVmac239 Pr55Gag isoform, SIV p43, suppresses proteolytic cleavage of Pr55Gag.

  2007cites this paper
• Myristoylcoa:Protein N‐Myristoyltransferase

  2006cites this paper
• AZT and AZT-monophosphate Prodrugs Incorporating HIV-protease Substrate Fragment: Synthesis and Evaluation as Specific Drug Delivery Systems

  2006cites this paper
• Phosphorylation and Proteolytic Cleavage of Gag Proteins in Budded Simian Immunodeficiency Virus

  2005cites this paper
• Proteolytic cleavage events in the maturation of HIV-1 reverse transcriptase

  2005cites this paper
• Construction and characterization of chimeric BHIV (BIV/HIV-1) viruses carrying the bovine immunodeficiency virus gag gene.

  2005cites this paper
• Enigmas and paradoxes: the genetic diversity and prevalence of the primate lentiviruses.

  2004cites this paper
• Important Role for the CA-NC Spacer Region in the Assembly of Bovine Immunodeficiency Virus Gag Protein

  2004cites this paper
• Bio-support vector machines for computational proteomics

  2004cites this paper
• Quantitation of HLA Class II Protein Incorporated into Human Immunodeficiency Type 1 Virions Purified by Anti-CD45 Immunoaffinity Depletion of Microvesicles

  2003cites this paper
• Characterization of a Novel Simian Immunodeficiency Virus (SIVmonNG1) Genome Sequence from a Mona Monkey (Cercopithecus mona)

  2003cites this paper
• Characterization and Comparison of Recombinant Simian Immunodeficiency Virus from Drill (Mandrillus leucophaeus) and Mandrill (Mandrillus sphinx) Isolates

  2003cites this paper
• Mining Biological Data Using Self-Organizing Map

  2003cites this paper
• Support vector machines for predicting HIV protease cleavage sites in protein

  2002cites this paper
• Replacement of the P1 Amino Acid of Human Immunodeficiency Virus Type 1 Gag Processing Sites Can Inhibit or Enhance the Rate of Cleavage by the Viral Protease

  2002influential citation
• Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus

  2002cites this paper
• Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging.

  2002cites this paper
• Computational studies on tetrahydropyrimidine-2-one HIV-1 protease inhibitors: improving three-dimensional quantitative structure-activity relationship comparative molecular field analysis models by inclusion of calculated inhibitor- and receptor-based properties.

  2002cites this paper
• Alteration of Zinc-Binding Residues of Simian Immunodeficiency Virus p8NC Results in Subtle Differences in Gag Processing and Virion Maturation Associated with Degradative Loss of Mutant NC

  2001cites this paper
• Characterization of Novel Simian Immunodeficiency Viruses from Red-Capped Mangabeys from Nigeria (SIVrcmNG409 and -NG411)

  2001cites this paper
• Mutations within the Putative Membrane-Spanning Domain of the Simian Immunodeficiency Virus Transmembrane Glycoprotein Define the Minimal Requirements for Fusion, Incorporation, and Infectivity

  2001cites this paper
• Caprine arthritis encephalitis virus: evidence for a B/D-type assembly pathway in a C-type lentivirus replication.

  2001cites this paper
• HIV protease: enzyme function and drug resistance.

  2000cites this paper
• Ubiquitination of HIV-1 and MuLV Gag.

  2000cites this paper
• HIV-1 protease: maturation, enzyme specificity, and drug resistance.

  2000cites this paper
• Efficient Incorporation of HLA Class II onto Human Immunodeficiency Virus Type 1 Requires Envelope Glycoprotein Packaging

  2000cites this paper
• Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance.

  2000cites this paper
• HIV-I protease: Maturation, enzyme specificity, and drug resistance

  2000cites this paper
• Protection of Macaca nemestrina from Disease following Pathogenic Simian Immunodeficiency Virus (SIV) Challenge: Utilization of SIV Nucleocapsid Mutant DNA Vaccines with and without an SIV Protein Boost

  2000cites this paper
• A Human Nuclear Shuttling Protein That Interacts with Human Immunodeficiency Virus Type 1 Matrix Is Packaged into Virions

  2000cites this paper
• Actin-binding cellular proteins inside human immunodeficiency virus type 1.

  2000cites this paper
• Mutational Analysis of the Hydrophobic Tail of the Human Immunodeficiency Virus Type 1 p6Gag Protein Produces a Mutant That Fails To Package Its Envelope Protein

  1999cites this paper
• Simian Immunodeficiency Virus (SIV) from Sun-Tailed Monkeys (Cercopithecus solatus): Evidence for Host-Dependent Evolution of SIV within the C. lhoestiSuperspecies

  1999cites this paper
• Inhibitory constituents against HIV-1 protease fromAgastache rugosa

  1999cites this paper
• Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.

  1999cites this paper
• Coupled Integration of Human Immunodeficiency Virus Type 1 cDNA Ends by Purified Integrase In Vitro: Stimulation by the Viral Nucleocapsid Protein

  1999cites this paper
• Effect of substrate residues on the P2' preference of retroviral proteinases.

  1999cites this paper
• Macaques infected with cloned simian immunodeficiency virus show recurring nef gene alterations.

  1998cites this paper
• Artificial neural network model for predicting HIV protease cleavage sites in protein

  1998cites this paper
• Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.

  1998cites this paper
• Sequential Steps in Human Immunodeficiency Virus Particle Maturation Revealed by Alterations of Individual Gag Polyprotein Cleavage Sites

  1998cites this paper
• Ubiquitin Is Covalently Attached to the p6GagProteins of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus and to the p12Gag Protein of Moloney Murine Leukemia Virus

  1998cites this paper
• The regulation of sequential processing of HIV-1 Gag by the viral protease.

  1998cites this paper
• Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency.

  1998cites this paper
• Artificial neural network method for predicting HIV protease cleavage sites in protein

  1998cites this paper
• Structural analysis of inhibitor binding to HIV-1 protease: identification of a common binding motif

  1998cites this paper
• A Putative α-Helical Structure Which Overlaps the Capsid-p2 Boundary in the Human Immunodeficiency Virus Type 1 Gag Precursor Is Crucial for Viral Particle Assembly

  1998cites this paper
• Short and unexpectedly potent 3-pyrrolidinone type inhibitors of HIV-1 replication

  1998cites this paper
• Molecular Recognition of Cyclic Urea HIV-1 Protease Inhibitors*

  1998cites this paper
• The matrix protein of HIV-1 is not sufficient for assembly and release of virus-like particles.

  1998cites this paper
• Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors.

  1997cites this paper
• Infection of macaque monkeys with simian immunodeficiency virus: an animal model for neuro-AIDS.

  1997cites this paper
• Studies on the Symmetry and Sequence Context Dependence of the HIV-1 Proteinase Specificity*

  1997cites this paper
• Viral RNA binding properties of human immunodeficiency virus type-2 (HIV-2) nucleocapsid protein-derived synthetic peptides.

  1996cites this paper
• Dynamic interactions of the Gag polyprotein.

  1996cites this paper
• Molecular mechanics calculations on HIV-1 protease with peptide substrates correlate with experimental data.

  1996cites this paper
• Comparative morphology and structural classification of retroviruses.

  1996cites this paper
• Prediction of human immunodeficiency virus protease cleavage sites in proteins.

  1996cites this paper
• Cytoskeletal proteins inside human immunodeficiency virus type 1 virions

  1996cites this paper
• Portals of entry: uncovering HIV nuclear transport pathways.

  1996cites this paper
• Morphogenesis and Maturation of Retroviruses

  1996cites this paper
• Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method

  1996cites this paper
• Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation

  1996cites this paper
• Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity.

  1996cites this paper
• Naturally occurring protease inhibitors potent against the human immunodeficiency virus.

  1996cites this paper
• A heterologous substrate assay for the HIV-1 protease engineered in Escherichia coli.

  1996cites this paper
• Human immunodeficiency viruses.

  1996influential citation
• Neural network prediction of the HIV-1 protease cleavage sites.

  1995cites this paper
• Viral protein X.

  1995cites this paper
• Expression and purification of active form of HIV-1 protease from E.coli.

  1995cites this paper
• The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity

  1995cites this paper
• Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.

  1995cites this paper
• Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses

  1995cites this paper
• Limited Sequence Diversity of the HIV Type 1 Protease Gene from Clinical Isolates and in Vitro Susceptibility to HIV Protease Inhibitors

  1995cites this paper
• First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses.

  1995cites this paper